Press releases

May 12, 2015

Verlyx Pharma appoints internationally renowned hepatologist and researcher, Kris Kowdley, MD, to its Scientific Advisory Board.

April 14, 2015

Patrick Colin is appointed Chief Development Officer of Verlyx Pharma, a specialty pharmaceutical company developing products to treat liver disease.

March 3, 2015

François Legault is appointed Chairman of the Board of Verlyx Pharma, a biopharmaceutical company developing products targeting liver diseases.